NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/25/2025
Back to search
Official data from USPTO
CAIDYA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
03/25/2025
Classification
Registered
Trademark type
Combined
Nice classes
35, 42, 45
Filing date
12/22/2022
Registration date
03/25/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/25/2025
Last transaction
03/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2023-09-00
First use in commerce
2023-09-00
Drawing code
3
Owner type
03
Owner location
Morrisville, NC, US
Examiner
GANDARA, KEYLA MARIA
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized wording "CAIDYA" on the left with the stylized letters "C" and "A" intertwined together to form an infinity symbol, a vertical line in the middle and three Chinese characters on the right.
Holders and representatives
Holders
Clinipace, Inc.
Representatives
Margarita Wallach, Esq. McCarter & English, LLP
Technical classification
Nice Classes
Class 35Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of pharmaceuticalmedicalhealthcarelife sciences companies to assist them with clinical researchclinical trials and applications for drugbiologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) servicesbusiness management in the field of clinical trialsclinical data management
Class 42
Contract research organization (CRO) servicesmonitoring of clinical trials for drugsbiologics and devices of pharmaceuticalmedicalhealthcarelife sciences companies for quality control purposesclinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areasin particular gastroenterologynephrologyurologyoncology; consulting services in the field of scientific research in the nature of conducting clinical trials in the pharmaceutical industrythe biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for othersproviding implementation services relating to the development and validation of drugsbiologics and medical devices; Software as a service (SaaS) services featuring software for accessingcollectingmanagingtrackinganalyzingreporting data and information on clinical trials; Contract research organization (CRO) servicescustom technical writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports; Contract research organization (CRO) servicescustom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports for submission to regulatory authorities
Class 45
Providing independent review of clinical trials involving human subjectsreviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceuticalmedicalhealthcarelife sciences fields
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/25/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/06/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/06/2025
ALIE
ASSIGNED TO LIE
02/25/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/24/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/24/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/14/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
11/08/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
11/08/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/17/2024
GNRT
NON-FINAL ACTION E-MAILED
08/17/2024
CNRT
SU - NON-FINAL ACTION - WRITTEN
08/17/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
08/01/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/01/2024
IUAF
USE AMENDMENT FILED
06/12/2024
EISU
TEAS STATEMENT OF USE RECEIVED
06/12/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/17/2023
PUBO
PUBLISHED FOR OPPOSITION
10/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/27/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
09/07/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/07/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
09/07/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/01/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/01/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/01/2023
GNRT
NON-FINAL ACTION E-MAILED
06/01/2023
CNRT
NON-FINAL ACTION WRITTEN
06/01/2023
DOCK
ASSIGNED TO EXAMINER
05/19/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/20/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/19/2023
NWAP
NEW APPLICATION ENTERED
12/26/2022
Continuous trademark protection
Get notified about every new filing that threatens CAIDYA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.